Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psychosis, Schizophrenia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01190254
What this trial is testing

Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896)

Who this might be right for
Schizophrenia, ParanoidSchizophrenia, DisorganizedSchizophrenia, Undifferentiated
Organon and Co 306
Testing effectiveness (Phase 2)UnknownNCT02426983
What this trial is testing

Pilot Study Using an NMDA Antagonist to Modulate Transcranial Direct Current Stimulation (tDCS) Effects on Sensory Discrimination

Who this might be right for
Schizophrenia
University of Ottawa 12
Not applicableStudy completedNCT05445466
What this trial is testing

Causal Lesion Network Guided Treatment of Bipolar Mania With Transcranial Electrical Stimulation

Who this might be right for
Bipolar DisorderSchizo Affective Disorder
Beth Israel Deaconess Medical Center 14
Early research (Phase 1)Study completedNCT05342727
What this trial is testing

Transcranial Direct and Alternating Stimulation of the Prefrontal Cortex for Cognitive Improvement in Schizophrenia

Who this might be right for
SchizophreniaCognitive Dysfunction
The National Brain Mapping Laboratory (NBML) 50
Not applicableStudy completedNCT00248794
What this trial is testing

Cognitive Rehabilitation in Schizophrenia

Who this might be right for
Cognitive ImpairmentSchizophrenia
VA Office of Research and Development 59
Post-approval studies (Phase 4)Study completedNCT02625103
What this trial is testing

The Significance of Deviation in Time From the 12-hour Standard Serum-clozapine Monitoring.

Who this might be right for
Schizophrenia
Anders Fink-Jensen, MD, DMSci 48
Not applicableUnknownNCT00173069
What this trial is testing

A Study on Psychopathological Progress of Early Schizophrenia-Like Disorder (SOPRES)

Who this might be right for
Schizophrenia
National Taiwan University Hospital 324
Large-scale testing (Phase 3)Study completedNCT01683058
What this trial is testing

Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 74
Not applicableLooking for participantsNCT05671185
What this trial is testing

RTMS for Depressive, Positive and Negative Symptoms, and Physiological Indices of Schizophrenia Patients

Who this might be right for
Schizophrenia and Related Disorders
National Taiwan University Hospital 180
Not applicableStudy completedNCT04870996
What this trial is testing

RCT of tDCS Combined With Cognitive Training in Schizophrenia

Who this might be right for
Schizophrenia
CHAN SAU MAN, SANDRA 44
Not applicableActive Not RecruitingNCT05905003
What this trial is testing

AMP SCZ® Observational Study: PREDICT-DPACC

Who this might be right for
Clinical High RiskPsychosisRemission+1 more
Brigham and Women's Hospital 2,617
Not applicableStudy completedNCT05660070
What this trial is testing

Context-Aware Mobile Intervention for Social Recovery in Serious Mental Illness

Who this might be right for
SchizophreniaSchizoaffective DisorderMood Disorder, Psychotic
University of California, San Diego 46
Not applicableUnknownNCT05599373
What this trial is testing

Optimal rTMS for Cognitive Deficits and Negative Symptoms in Schizophrenia

Who this might be right for
SchizophreniaNegative Symptoms in SchizophreniaCognitive Impairment+2 more
Shanghai Mental Health Center 90
Testing effectiveness (Phase 2)Study completedNCT02281773
What this trial is testing

Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks in Patients With Schizophrenia on Stable Antipsychotic Treatment.

Who this might be right for
Schizophrenia
Boehringer Ingelheim 518
Large-scale testing (Phase 3)UnknownNCT01672554
What this trial is testing

Clinical Benefits of Seroquel XR in Anxiety Disorder

Who this might be right for
SchizophreniaAnxiety
Corporation de Recherche en Neuropsycho Pharmacologie de Quebec 40
Not applicableEnded earlyNCT05167396
What this trial is testing

REtinal and VIsual Cortical Response in Early PSYchosis

Who this might be right for
Prodromal SchizophreniaPsychotic EpisodeProdromal Symptoms+1 more
Centre Psychothérapique de Nancy 34
Testing effectiveness (Phase 2)Ended earlyNCT00669903
What this trial is testing

Study to Asses Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of AZD0328 in Patients With Schizophrenia

Who this might be right for
Schizophrenia
AstraZeneca 100
Testing effectiveness (Phase 2)Ended earlyNCT00548327
What this trial is testing

The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype

Who this might be right for
SchizophreniaMemory DisordersCognition Disorders
National Institute of Mental Health (NIMH) 11
Early research (Phase 1)Study completedNCT06276361
What this trial is testing

Pharmacokinetics, Safety and Tolerability of Different Formulations and Dose Strengths of Quarterly Risperidone (QUAR) in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Rovi Pharmaceuticals Laboratories 58
Not applicableUnknownNCT00172770
What this trial is testing

The Establishment of the Early Intervention Program for Patients With Schizophrenia

Who this might be right for
Schizophrenia
National Taiwan University Hospital 20
Next Page